Income statement revenue $189.95M (+20.7% YoY).Operating income $23.74M (-35.1% YoY).Pre-tax result $19.41M (-46.4% YoY).Net result $14.68M (-57.9% YoY).

Research, development and clinical trials: $31.63M (+98.5% YoY)
Selling, general and administrative: $57.83M (+31.2% YoY)
Other expense: $4.33M (+1024.9% YoY)
Income tax expense: $4.72M (+270.4% YoY)

Loading financials

Income statement income statement flow. Revenue $189.95M. Net result $14.68M.

Income statement revenue $189.95M (+20.7% YoY).Operating income $23.74M (-35.1% YoY).Pre-tax result $19.41M (-46.4% YoY).Net result $14.68M (-57.9% YoY).

Research, development and clinical trials: $31.63M (+98.5% YoY)
Selling, general and administrative: $57.83M (+31.2% YoY)
Other expense: $4.33M (+1024.9% YoY)
Income tax expense: $4.72M (+270.4% YoY)